The American company BioCryst has conducted clinical trials of the drug against influenza. Peramivir was effective when introducing it in the first 48 hours of illness. Working dose is 300 mg.
Within two weeks, the volunteers recorded the dynamics of flow of the flu. The first improvements were recorded after 22 hours after administration of the funds. All symptoms of the flu shot after 113 hours after illness onset. In placebo-treated volunteers were recovered through 134 hours.
Peramivir helps the body fight viral infection and outputs the influenza virus from the body. Paraver used in Japan and South Korea since 2010. The U.S. has filed an application for the drug in 2013. If the government will approve the drug, the Americans receives the first odnosnie drug against influenza.